Zhejiang CONBA Pharmaceutical Co.,Ltd.

Shanghai Stock Exchange 600572.SS

Zhejiang CONBA Pharmaceutical Co.,Ltd. EBT Margin for the year ending December 31, 2023: 11.40%

Zhejiang CONBA Pharmaceutical Co.,Ltd. EBT Margin is 11.40% for the year ending December 31, 2023, a 15.96% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

Zhejiang CONBA Pharmaceutical Co.,Ltd. EBT Margin for the year ending December 31, 2022 was 9.83%, a -75.91% change year over year.
Zhejiang CONBA Pharmaceutical Co.,Ltd. EBT Margin for the year ending December 31, 2021 was 40.82%, a 215.03% change year over year.
Zhejiang CONBA Pharmaceutical Co.,Ltd. EBT Margin for the year ending December 31, 2020 was 12.96%, a 1,853.36% change year over year.
Zhejiang CONBA Pharmaceutical Co.,Ltd. EBT Margin for the year ending December 31, 2019 was -0.74%, a -104.93% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

Shanghai Stock Exchange: 600572.SS

Zhejiang CONBA Pharmaceutical Co.,Ltd.

CEO	Mr. Guoliang Luo
IPO Date	April 12, 2004
Location	China
Headquarters	No. 568, Binkang Road
Employees	8,411
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of traditional Chinese medicines and botanical products in China. It offers chemical medicines, Chinese patent medicines, eye health products, nutritional supplements, health supplies, healthy daily necessities and food products, and other personal care products. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China. Zhejiang CONBA Pharmaceutical Co.,Ltd. is a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd.

Key trends

Past 5 years